BRIEF-Auxilium expects to submit supplemental biologics license application for Xiaflex to FDA in Q1

Mon Nov 18, 2013 7:26am EST

Nov 18 (Reuters) - Auxilium Pharmaceuticals Inc : * Announces results of the xiaflex in dupuytren's multicord contracture trial * Says expects to submit supplemental biologics license application to FDA in

Q1 of 2014 on xiaflex * Source text for Eikon * Further company coverage

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.